In addition to the overall survival, patients' relapse-free survival probabilities of TNS2 expression in 3 lung cancer datasets (GSE50081, GSE41271, and GSE31210) and 1 breast cancer dataset (GSE1456_U133A) were available and analyzed by using the online survival analysis tools at PROGgeneV2. This evidence concerns the gene TNS2 and lung carcinoma.